Sunday 29th March 2020
Sunday, 29th of March 2020
Home / Health / COVID-19: Fatality ratio low at 2.3%, 80% of cases are mild

COVID-19: Fatality ratio low at 2.3%, 80% of cases are mild

Technical Officer For Laboratory Strengthening, World Health Organization (WHO), Dr Dhamari Naidoo, has said that Coronavirus (COVID-19)’s current case fatality ratio was low at 2.3 percent, while 80 percent of cases are mild.

Dr Tedros Adhanom Ghebreyesus  COVID-19: Fatality ratio low at 2.3%, 80% of cases are mild Tedros Adhanom Ghebreyesus
Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation (WHO). Photo credit: AFP / FABRICE COFFRINI / Getty Images

Naidoo said this while presenting a report on the epidemiological characteristics of COVID-19 at the Nigeria Centre for Disease Control (NCDC), Journal Club Monthly Research Presentation, on Wednesday, February 19, 2020 in Abuja.

This month’s Journal Club Research Presentation was targeted at  highlighting key facts and debunking myths on the dreaded COVID-19.

The Technical Officer said that there had been a high level of misinformation on COVID-19, especially on the social media, adding that Nigerians needed to be aware of credible sources of accurate information on COVID-19.

ALSO READ:  Coronavirus: Preparedness high to stop importation into Nigeria – Minister

She advised Nigerians to visit ncdc.gov.ng and the Federal Ministry of Health website for recent and accurate information on the disease.

Naidoo noted that though COVID-19 had spread to some parts of the world, “we have seen a downward trend with no sustained transmission in affected countries”.

“There is still much to learn about the disease and how to respond effectively,” she said.

She added that Nigeria had a surveillance case definition to identify suspect cases of COVID-19.

“We now have four laboratories where the disease can be rapidly tested in the country.

“The centres are located at the National Reference Laboratory, Abuja, LUTH, Irrua Specialist Teaching Hospital, and the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID),” she said.

%d bloggers like this: